Endotoxin testing milestone reached with European Pharmacopoeia’s animal shift
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
List view / Grid view
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
17 August 2012 | By Biogen Idec
New collaboration in support of Science, Technology, Engineering, and Math education...
15 August 2012 | By Phenomenex
Fasha Mahjoor, founder and CEO of Phenomenex, will leap off the 87th floor of The Shard in London on the 3rd of September...
15 August 2012 | By Maitland
Study to test Debio 0932 in patients with advanced non-small cell lung cancer...
15 August 2012 | By Novartis
Results of two Phase III studies...
15 August 2012 | By Bristol-Myers Squibb Company
Patient management programs for Sprycel® patients launched...
15 August 2012 | By GlaxoSmithKline
GSK has reached agreement to divest the majority of its “Classic Brands” in Australia...
14 August 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has grown again in the current financial year...
13 August 2012 | By Patheon
Patheon Inc. announced that Mark J. Kontny is no longer with the company...
13 August 2012 | By Sanofi
Breakthrough device design talks patients and caregivers through the injection process...
13 August 2012 | By Abbott
40 students living with CF each to receive a $2,500 CFCareForward Scholarship...
13 August 2012 | By Roche
First major treatment advance in more than 25 years for sight-threatening condition...
13 August 2012 | By AstraZeneca
NEXIUM 20mg retail launch targeted for 2014, subject to regulatory approval...
10 August 2012 | By Pfizer
Pfizer Inc. announced the Phase 3 INTORACT trial (B1771006) did not meet its primary endpoint...
10 August 2012 | By Roche
Phase III study met its co-primary endpoint...
9 August 2012 | By Phenomenex Inc
Phenomenex introduces two new Tabless Tube Holder accessories...